Literature DB >> 3986988

Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.

E D Ryan, A F Clark, B G Mobbs, T C Ooi, D J Sutherland, E R Tustanoff.   

Abstract

In 1981 a quality control (QC) program for estrogen and progesterone receptor assays was organized among six laboratories in Ontario, Canada. Twenty-three vials of lyophilised cytosol prepared from human breast tumor tissues were analysed by each laboratory over a two-year period. Samples of each batch of QC material were analysed at least twice: either in the same batch or on separate occasions. The present study demonstrates the stability of the QC material, defines the relative accuracy of the receptor assays, and provides estimates of within-batch and between-batch precision of the receptor assays.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986988     DOI: 10.1016/s0009-9120(85)80018-7

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.

Authors:  S M Thorpe
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

2.  Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group.

Authors:  M A Blankenstein
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

3.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

4.  Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.

Authors:  G Gasparini; F Pozza; R Dittadi; S Meli; S Cazzavillan; P Bevilacqua
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

Authors:  L L Shek; W Godolphin; J J Spinelli
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.